Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review

@article{Cooper2020PsychosocialIF,
  title={Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review},
  author={Ruth E. Cooper and Neelam Laxhman and Nadia Crellin and Joanna Moncrieff and Stefan Priebe},
  journal={Schizophrenia Research},
  year={2020},
  volume={225},
  pages={15-30}
}

Figures and Tables from this paper

Opinion Piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia
TLDR
It is recommended that healthcare providers should be encouraged to develop a psychosocial treatment package for people with psychosis or schizophrenia that provides a realistic possibility of minimising antipsychotic exposure.
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders
TLDR
This large study reveals that patients are commonly unhappy about the idea of taking antipsychotics on a continuing or life-long basis and professional support for people who want to try to reduce or stop medication is valued.
Psychological Interventions for Young People With Psychotic Disorders: A Systematic Review
TLDR
There is some evidence that psychological interventions are effective for young people with psychotic disorders, however, with regard to symptom severity, psychotherapy does not outperform control conditions, and the results do not strongly favor any specific type of treatment.
Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
TLDR
There is a good rationale for supporting patients who wish to stop their medication, especially given the patient choice agenda favoured by NICE, and guidelines to summarise evidence on ways to reduce medication would be useful.
Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation
TLDR
Concerns about risk and other barriers means that clinicians are often reluctant to implement reduction or discontinuation of antipsychotic medication, so more research and guidance on how to minimise the risks is required to enable clinicians to engage more constructively with service users requests.
Fear of relapse in schizophrenia: a mixed-methods systematic review
TLDR
Clinicians should be aware that fear of relapse exists and appears to be positively associated with depression and suicide ideation, and negatively associated with self-esteem, and to measure wellbeing rather than psychopathology.
Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication
TLDR
This sample shows it is possible for people who experience mania and psychosis to successfully discontinue antipsychotics and safely manage the impact of any symptoms that emerge as a result of the withdrawal process or other life stressors that arise afterwards.
Effectiveness of sensory modulation for people with schizophrenia: A multisite quantitative prospective cohort study.
TLDR
Evidence is provided to suggest that sensory modulation interventions can be complementary to standard care when utilised appropriately in clinical settings and also suggest that the sensory profile of people with schizophrenia is different to that of the general population and this may have clinical implications.
Using Open Questions to Understand 650 People's Experiences With Antipsychotic Drugs.
TLDR
Clinicians should pay more attention to the need for respectful and collaborative patient-prescriber relationships, including providing the full range of information about antipsychotics, including potential benefits and harms, difficulties withdrawing, and information on alternatives treatments such as psychological therapies.
How important are informed consent, informed choice, and patient-doctor relationships, when prescribing antipsychotic medication?
  • J. Read
  • Medicine, Psychology
    Journal of mental health
  • 2022
TLDR
Information, satisfaction with the process, and the prescriber relationship were all positively related to three self-reported outcomes: reduction of problems the drugs were prescribed for, general helpfulness, and quality of life.
...
1
2
3
...

References

SHOWING 1-10 OF 102 REFERENCES
Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial
TLDR
Preliminary evidence is provided that CT is an acceptable and effective treatment for people with psychosis who choose not to take antipsychotic medication, and an adequately powered randomized controlled trial is warranted.
Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
TLDR
The 20-year data indicate that, longitudinally, after the first few years, antipsychotic medications do not eliminate or reduce the frequency of psychosis in schizophrenia, or reduction the severity of post-acute psychosis, although it is difficult to reach unambiguous conclusions about the efficacy of treatment in purely naturalistic or observational research.
The Benefits of Individual Psychotherapy for People Diagnosed With Schizophrenia: A Meta-Analytic Review
TLDR
Psychodynamic, cognitive-behavioral, and non-psychodynamic supportive therapies were all associated with improvement in functioning and similar effect sizes were found between psychotherapy combined with antipsychotic medication and psychotherapy used without medication.
Psychosocial treatment, antipsychotic postponement, and low‐dose medication strategies in first‐episode psychosis: A review of the literature
TLDR
These projects demonstrate the feasibility of a carefully supervised approach to medication‐free research and also suggest a strategy for integrating biological, psychological and social treatment components in early‐episode psychoses.
A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia.
TLDR
It is suggested that the Soteria paradigm yields equal, and in certain specific areas, better results in the treatment of people diagnosed with first- or second-episode schizophrenia spectrum disorders when compared with conventional, medication-based approaches.
...
1
2
3
4
5
...